# Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans

> **NCT03077360** · NA · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 62 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Pre-diabetes
- Obesity

## Interventions

- **BEHAVIORAL:** Lifestyle

## Key facts

- **NCT ID:** NCT03077360
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2020-11-19
- **Final completion:** 2020-11-19
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2022-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03077360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03077360, "Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03077360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*